Atif Khan, MD
Radiation Oncology · New Brunswick, NJNPI 1255545653
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,457 of the $2,011 with a category attached, or 72.5%. Accuray Incorporated accounts for 95.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $1,927 and has fallen 98.7% since, to $25 in 2025.
Across 14 payments — averaging $143.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Accuray Incorporated$2K
- Bristol Myers Squibb$59
- Beone Medicines USA, Inc.$25
Across 18 payments — averaging $259,798 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$4.2M
- Clovis Oncology, Inc.$345K
- Siemens Medical Solutions USA, Inc.$164K
What the payments were for
- Speaking & faculty fees$724%
- Travel & lodging$1,45772%
- Food & beverage$48124%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Accuray Incorporated | 10 | $1,927 |
| Bristol Myers Squibb | 3 | $59 |
| Beone Medicines USA, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CyberKnife System$1,676
- TomoTherapy System$1,676
How this compares
$2,011 in reported general payments places this provider in the 75th percentile of 132 radiation oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 49 | $772 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in New Brunswick
- Salma JabbourNew Brunswick$163K
- Sharad GoyalNew Brunswick$3K
- Bruce HafftyNew Brunswick$1K
- Lara HathoutNew Brunswick$592
- Michael GreenbergCherry Hill$335K
- Glen GejermanHackensack$180K
- Marc RudoltzWest Orange$166K
- Edward SoffenMonroe Twp$50K
- Adnan DanishWayne$45K
- Timothy ChenPennington$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.